drugset / Trial / NCT03423771

Phase I/II Clinical Trial of NPF-08 in Healthy Volunteers

NCT03423771

Phase 1/2 Completed 90 enrolled Nihon Pharmaceutical Co., Ltd
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

Japanese male healthy volunteers will receive NPF-08. The efficacy of NPF-08 will be assessed by intestinal cleaning degree. The safety of NPF-08 will be evaluated based on adverse events and adverse drug reactions observed from the date of administration to 7 days after administration.

Timeline

Start
2017-10-06
Primary completion
2018-02-23
Completion
2018-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject NPF-08 Unknown Oral

Indications

No indication recorded.